Dr. Ruben Mesa, MD, director of the Mays Cancer Center, discusses the importance of developing racially inclusive clinical trials in myeloproliferative neoplasms (MPNs). Watch the interview.

Dear Mays Cancer Center community, I’m delighted to share with you that as of today, Aug. 13, 2020, the Mays Cancer Center has officially been renewed as a National Cancer Institute-designated cancer center for the next five years. After a highly competitive process, the National Cancer Institute empowers us to continue our mission to Decrease […]

WQAD, a television station in Moline, Ill., aired the Ivanhoe Broadcast News story about research conducted by Darpan Patel, PhD, associate professor of research in the School of Nursing, and Pratap Kumar, PhD, from the Department of Molecular Medicine. The researchers decided to test cork tree bark extract, also called Nexrutine, to fight dangerous body […]

Dr. Ruben Mesa, MD, director of the Mays Cancer Center, says racial and ethnic disparities in cancer clinical trials impact diagnostics and treatment of minority populations and explains the importance of diversity in clinical trials. Read the story.

Dr. Ruben Mesa, MD, director of the Mays Cancer Center, discusses the racial and ethnic disparities in cancer clinical trials and the efforts being made to increase diversity in clinical trials. Read the story.